Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Calmels

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Cancers|June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling DonorRaynier Devillier, Boris Calmels, Sophie Guia, et al.
Experimental Hematology|March 7, 2013
Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantationAngela Granata, Luca Castagna, Roberto Crocchiolo, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
Bulletin Du Cancer|November 5, 2016
[Modalities for preparation, cryopreservation, thawing of hematopoietic stem cells and precautions for infusion to patient: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Florence Boulanger, Véronique Decot, Geneviève Bulliard, et al.
Cancer|October 26, 2012
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseasesRoberto Crocchiolo, Benjamin Esterni, Luca Castagna, et al.
American Journal of Hematology|August 23, 2012
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Alberto Vazquez, Roberto Crocchiolo, et al.
Transfusion|June 22, 2007
Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis productBoris Calmels, Claude Lemarié, Benjamin Esterni, et al.
Plos One|September 28, 2011
Characterisation of genome-wide PLZF/RARA target genesSalvatore Spicuglia, Christelle Vincent-Fabert, Touati Benoukraf, et al.
Plos One|March 6, 2020
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSFSylvain Garciaz, Patrick Sfumato, Angela Granata, et al.
Experimental Hematology|October 2, 2012
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experienceJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancers|June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling DonorRaynier Devillier, Boris Calmels, Sophie Guia, et al.
Experimental Hematology|March 7, 2013
Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantationAngela Granata, Luca Castagna, Roberto Crocchiolo, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
Bulletin Du Cancer|November 5, 2016
[Modalities for preparation, cryopreservation, thawing of hematopoietic stem cells and precautions for infusion to patient: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Florence Boulanger, Véronique Decot, Geneviève Bulliard, et al.
Cancer|October 26, 2012
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseasesRoberto Crocchiolo, Benjamin Esterni, Luca Castagna, et al.
American Journal of Hematology|August 23, 2012
Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Alberto Vazquez, Roberto Crocchiolo, et al.
Transfusion|June 22, 2007
Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis productBoris Calmels, Claude Lemarié, Benjamin Esterni, et al.
Plos One|September 28, 2011
Characterisation of genome-wide PLZF/RARA target genesSalvatore Spicuglia, Christelle Vincent-Fabert, Touati Benoukraf, et al.
Plos One|March 6, 2020
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSFSylvain Garciaz, Patrick Sfumato, Angela Granata, et al.
Experimental Hematology|October 2, 2012
Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experienceJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Pageof 7